Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07039396 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot Ulcers

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 12, 2026 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study sites: 2 to 3v9
  2. Primary completion date: Dec 1, 2025 to May 1, 2026
    • Study completion date: Jan 1, 2026 to Jun 1, 2026
    v8
  3. Study sites: 1 to 2v7
  4. Trial status: Not Yet Recruiting to Recruitingv6 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Nov 3, 2025 to Dec 1, 2025
    • Study completion date: Dec 30, 2025 to Jan 1, 2026
    • Start date changed from estimate of Jul 14, 2025 to Aug 26, 2025
  5. 3 versions Re-verified since Jul 3, 2025, no change to tracked fieldsv3-v5
  6. Interventions: NeoThelium FT (Other) to NeoThelium FT (HCT/P 361) (Other)v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Diabetic Foot Ulcers
Trial Details
NCT Number NCT07039396
Lead Sponsor NuScience Medical Biologics, LLC
Collaborators: SygNola, LLC
Conditions
(from sponsor)		 Diabetic Foot Ulcer
Related terms Diabetic Foot
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov